Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
May inform antiarrhythmic choice after cardioversion; leaves open need for safety data versus modern agents.
Juul‐Möller et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: